2-Hydroxyglutarate in onco-pathway: a metabolic driver of proto-oncogene activation
Masthan Thamim, Debdas Dhabal, M. M. Balamurali, Krishnan Thirumoorthy · 2026
Read 2-Hydroxyglutarate in onco-pathway: a metabolic driver of proto-oncogene activation by Masthan Thamim, Debdas Dhabal, M. M. Balamurali, Krishnan Thirumoorthy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13171342.txt.
Description
Thamim and three colleagues review a waste product of cell chemistry that can switch on cancer traits in twenty twenty-six. The compound, called 2HG, builds up when cancer cells rewire how they make energy. It comes in two mirror forms, like left and right hands. Both forms mimic a normal cell compound and block the enzymes that use it.
That block scrambles gene tags, cell repair, and growth signals, which can start and spread tumors. The two mirror forms act in unlike ways on these paths. The review pulls this picture together and weighs the compound as a marker and drug target. Blocking its effects could help some patients, they argue.
Catalog record
| CREATOR | Masthan Thamim, Debdas Dhabal, M. M. Balamurali, Krishnan Thirumoorthy |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 82 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |